Can targeted intervention in CRC patients'relatives influence screening behaviour? A pilot study

Colorectal Disease

Volumn 10, Issue 2, 2008, Pages 179-186

  Stephens, Jacqueline H ^a,b   Moore, J W E ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Colorectal neoplasms; First degree relative; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; INFORMATION DISSEMINATION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STANDARDIZATION;

CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PILOT PROJECTS; SOUTH AUSTRALIA;

EID: 38348998638     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2007.01258.x     Document Type: Article

References (29)

1. Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR). (2003) Cancer in Australia 2000, AIHW cat. no. CAN 18. AIHW, Canberra.
2. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM et.al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996; 348:1472-77.
3. Kronberg O, Penger C, Olsen J, Forgensen OD et.al. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996; 348:1467-71.
4. Mandel JS, Bond JH, Church TR, Snover DC et.al. Reducing mortality from colorectal cancer by screening for fecal occult blood. [published erratum appears in N Engl J Med 1993; 329: 672.]. N Engl J Med 1993; 328:1365-71.
5. Mandel JS, Church TR, Bond JH, Ederer F et.al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343:1603-7.
6. Cali RL, Pitsch RM, Thorson AG, Watson P et.al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993; 36:388-93.
7. Axon AT, Boyle P, Riddell RH, Grandjouan S et.al. Summary of working party on the surveillance of premalignant lesions. Am J Gastroenterol 1994; 89:S160-68.
8. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC et.al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterol 1994; 107:934-40.
9. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ et.al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994; 331:1669-74.
10. Rozen P, Fireman Z, Figer A, Legum C et.al. Family history of colorectal cancer as a marker of potential malignancy within a screening program. Cancer 1987; 60:248-54.
11. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. (2005) Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. The Cancer Council Australia and Australian Cancer Network, Sydney.
12. Harris MA, Byles JE. A survey of screening compliance among first-degree relatives of people with colon cancer in New South Wales. J Med Screen 1997; 4:29-34.
13. Morrow GR, Way J, Hoagland AC, Cooper R. Patient compliance with self-directed Haemoccult testing. Prev Med 1982; 11:512-20.
14. MacRae FA, Hill DJ, St John DJ, Ambikapathy A et.al. Predicting colon cancer screening behavior for health beliefs. Prev Med 1984; 13:115-26.
15. Byles JE, Sanson-Fisher RW, Redman S, Reid AL et.al. Early detection of colorectal cancer: A profile of current practice. Cancer Detect Prev 1992; 16:245-52.
16. Thrasher JF, Cummings KM, Michalek AM, Mahoney MC et.al. Colorectal cancer screening among individuals with and without a family history. J Public Health Management Practice 2002; 8:1-9.
17. Weller DP, Owen N, Hiller JE, Willson K et.al. Colorectal cancer and its prevention: Prevalence of beliefs, attitudes, intentions and behaviour. Aust J Public Health 1995; 19:19-23.
18. Farrands PA, Hardcastle JD, Chamberlain J, Moss S. Factors affecting compliance with screening for colorectal cancer. Community Med 1984; 6:12-9.
19. Hardcastle JD, Balfour TW, Amar SS. Screening for symptomless colorectal cancer by testing for occult blood in general practice. Lancet 1980; 1:791-3.
20. Dent O, Goulston K. Socio-demographic correlates of intended acceptance of colorectal screening. In: Annual scientific meeting of the Gastroenterological Society of Australia held in Brisbane, 14 and 15 May, 1979. Abstracts. Aust N Z J Med 1980; 10:107-16.
21. Kewenter J, Bjork S, Haglind E, Smith L et.al. Screening and rescreening for colorectal cancer: A controlled trials of faecal occult blood testing in 27,700 subjects. Cancer 1988; 62:645-51.
22. Dent OF, Bartrop R, Goulston KJ, Chapuis PH. Participation in faecal occult blood testing for colorectal cancers. Soc Sci Med 1983; 17:17-23.
23. Dolan JG, Frisina S. Randomized controlled trial of a patient decision aid for colorectal cancer screening. Med Decis Making 2002; 22:125-39.
24. Kinney AY, Choi YA, De Vellis B, Kobetz E et.al. Interest in genetic testing among first-degree relatives of colorectal cancer patients. Am J Prev Med 2000; 18:249-52.
25. Harris MA, Treloar CJ, Byles JE. Colorectal cancer screening: discussions with first degree relatives. Aust N Z J Public Health 1998; 22:826-8.
26. Janda M, Stanton WR, Hughes K, Del Mar C et.al. Knowledge, attitude and intentions related to colorectal cancer screening using faecal occult blood tests in a rural Australian population. Asia Pac J Public Health 2003; 15:50-6.
27. Petersen GM, Brensinger JD, Johnson KA, Giardiello FM. Genetic testing and counselling for hereditary forms of colorectal cancer. Cancer 1999; 86:2540-50.
28. Nakama H, Fukazawa K. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp. Hepatogastroenterology 2002; 49:157-9.
29. Markey K, Axel L, Ahnen D. Basic concepts for genetic testing in common hereditary colorectal cancer syndromes. Curr Gastroenterol Rep 2002; 4:404-13.